Severity
Moderate
FDA Drug recall · Reported August 31, 2022
CGMP Deviations: product held outside appropriate storage temperature conditions.
Family Dollar Stores, Llc. recalled READY IN CASE MICON 7 DAY 1.59 OZ SKU 939212 READY IN CASE MICON 3 DAY COMBO PACK SKU 9… - a moderate-severity action.
READY IN CASE MICON 7 DAY 1.59 OZ SKU 939212 READY IN CASE MICON 3 DAY COMBO PACK SKU 9… was recalled by Family Dollar Stores, Llc. in August 31, 2022. Reason: CGMP Deviations: product held outside appropriate storage temperature conditions.. Check the official notice for the remedy. Verify recall #D-1397-2022 with the FDA Drug before acting.
The recall
Family Dollar Stores, Llc. issued this moderate-severity FDA Drug recall-CGMP Deviations: product held outside appropriate storage temperature conditions..
Sourced from official FDA Drug enforcement records. Verify recall #D-1397-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1397-2022) was formally reported on August 31, 2022, with the manufacturer initiating the action on June 23, 2022. It is classified under Moderate severity (Class II), with a current status of Ongoing. Family Dollar Stores, Llc. is listed as the recalling firm, operating out of Chesapeake, VA. Federal records list the affected scope as Unknown.
The documented reason for this recall is: CGMP Deviations: product held outside appropriate storage temperature conditions. Distribution data in the federal record shows the product reached: Nationwide within the United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
Unknown
Related Recalls
6
5 from same agency
READY IN CASE MICON 7 DAY 1.59 OZ SKU 939212 READY IN CASE MICON 3 DAY COMBO PACK SKU 902373 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
CGMP Deviations: product held outside appropriate storage temperature conditions.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-1397-2022 |
| Date reported | August 31, 2022 |
| Date initiated | June 23, 2022 |
| Recalling firm | Family Dollar Stores, Llc. |
| Firm location | Chesapeake, VA |
| Affected scope | Unknown |
| Distribution | Nationwide within the United States |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported August 31, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.